Daily coverage of equity markets, sectors, and major indices.
In-depth reporting on U.S. and global stock markets, including index performance, sector rotation, earnings reactions, volatility trends, and notable single-stock moves. Designed to help traders and investors understand what is driving price action across equities.
29,706 total articles
Braveheart Bio filed to go public in the United States seeking a valuation of as much as $1.2 billion. The San Francisco-based clinical-stage company plans to offer 18.8 million shares at $15 to $17 each to raise $318.8 million, with plans to use proceeds to further develop its lead candidate BHB-1893 and support R&D and corporate needs.
BTIG has named Take-Two Interactive a top pick, reiterating an Outperform rating and assigning a $285 price target as the studio prepares to launch Grand Theft Auto VI on November 19. The brokerage is forecasting substantial bookings for fiscal 2027, driven primarily by GTA VI unit sales and premium pricing assumptions, while flagging unanswered qu…
Myers Industries fell in pre-market trade after reporting Q2 2026 results that featured an adjusted EPS of $0.53, beating expectations by $0.21, but revenue of $176.2 million that missed the $208.9 million consensus. The revenue shortfall, rising input cost concerns and a stock that had already rallied sharply contributed to the company-specific we…
HSBC said concerns that hyperscalers may be overspending have become the primary narrative shaping AI-related equity flows. The bank's clustering model, created by analyst Alastair Pinder, partitions the market into five regimes and assigns probabilities to each, indicating potential sector rotations depending on which narrative prevails.
Colliers International shares rose 8.7% in pre-market trading after the company reported second-quarter 2026 results that exceeded analyst expectations for both revenue and earnings. Highlights include double-digit consolidated revenue growth, higher Adjusted EBITDA and EPS above consensus, and management's reaffirmation of mid-teens percentage gro…
Meta Platforms shares tumbled nearly 10% in pre-market trading to $527.24, hovering just above the 52-week low of $520.26, after second-quarter results showed an EPS miss of 13.81% despite revenue edging 1% above estimates. The stock reaction centers on a sharp operating margin contraction of 600 basis points and a lack of guidance on 2027 capital …
Mastercard reported higher second-quarter profit as resilient consumer spending and elevated transaction values helped drive an increase in transaction volumes. Gross dollar volume rose 8% to $2.9 trillion and net revenue increased 14% to $9.3 billion, while net income reached $4.4 billion, or $4.97 per share. Growth in cross-border activity and th…
Two large power companies, Constellation Energy (CEG) and Vistra Energy (VST), have both underperformed year-to-date yet occupy differing positions in the race to supply AI-era data centers. CEG is concentrated on nuclear baseload with long-term offtakes and next-generation nuclear investments, trading at a premium multiple. VST operates a mixed po…
Leonardo DRS rallied after delivering second-quarter results that exceeded analyst expectations, raising full-year guidance and unveiling a $450 million all-cash deal for Raft LLC. The combination of stronger-than-expected earnings, upgraded forecasts and an acquisition aimed at bolstering AI capabilities for national security customers helped push…
Mastercard stock rose sharply in pre-market trading after the company posted stronger-than-expected second-quarter results. Net income climbed to $4.4 billion, or $4.97 per share, driven by solid transaction volumes and cross-border travel payment flows. Analyst upgrades and favorable positioning amplified the market response even as macroeconomic …
Rio Tinto shares rose more than 3% in London after Berenberg and Goldman Sachs upgraded the stock to Buy following the miner's July 29 first-half results. Analysts cited an appealing valuation relative to peers, stronger cash flow and a growing copper franchise as reasons for the move, while pointing to ongoing cost savings and potential proceeds f…
U.S. equity futures advanced on Thursday after Microsoft posted a robust fiscal fourth-quarter beat and signaled its AI investments are translating into demand. Gains were restrained by a hawkish Federal Reserve tone and rising oil prices amid escalating Middle East conflict. Individual corporate results produced volatile premarket moves, with Quan…
Regeneron Pharmaceuticals surged in pre-market trading after reporting second-quarter 2026 results that significantly outpaced analyst forecasts. Adjusted EPS of $14.29 topped consensus by $3.71, and revenue of $4.29 billion beat expectations by a wide margin. Record sales across key franchises and the full repayment of the Sanofi Development Balan…
Regeneron reported second-quarter revenue and profit that exceeded Wall Street expectations, driven by robust global sales of Dupixent and rising uptake of a higher-dose formulation of Eylea in the U.S. The company also completed repayment of an outstanding development balance to Sanofi, a move cited as supportive of margin improvement for the rema…
Avery Dennison Corp. stock climbed sharply in pre-market trading after the company reported second-quarter results that exceeded analyst estimates and provided full-year 2026 EPS guidance that sits at or above consensus. The move came despite a cautious analyst setup heading into the report and was supported by a positive broader market backdrop.
UBS has revised up its 2026 forecasts for China’s trade, pointing to AI-related commerce as a dominant factor in stronger-than-expected performance in the first half of 2026. Exports rose 18% year-over-year and imports 26% in H1, with AI-linked trade accounting for nearly half of growth. UBS now expects 2026 nominal export growth of about 18% and i…
Baxter International rallied sharply in pre-market trading after delivering second-quarter 2026 results that outpaced analyst forecasts on both earnings and revenue, and after lifting its full-year adjusted EPS guidance. The company also shifted to a two-segment reporting model aimed at clearer visibility into core operations. The combination of th…
Tenable shares plunged 15.0% in pre-market trading after the cybersecurity firm posted better-than-expected adjusted EPS and revenue for Q2 2026, but issued third-quarter revenue guidance below Street expectations and reported decelerating subscription growth. A notable analyst downgrade intensified the selloff, even as major U.S. indices moved hig…
Sonic Automotive fell 2.3% in pre-market trading after reporting Q2 2026 EPS of $1.82 on revenue of $3.9 billion, both edging past analyst expectations. The stock opened as low as $103.70 before recovering to $110.01, a move driven more by stretched valuations and profit-taking than by the quarterly numbers themselves. Market volatility tied to rec…
Porch Group shares jumped sharply in pre-market trading after the company posted second-quarter results that outperformed analyst expectations on revenue and earnings, raised 2026 guidance across key metrics, and disclosed a large stake held by BlackRock. Strong growth in the Insurance Services segment and a sizable rise in adjusted EBITDA helped f…
Altria Group reported second-quarter adjusted earnings per share of $1.48, narrowly below the LSEG consensus of $1.50, as weakness in premium cigarette and nicotine pouch demand weighed on results. Revenue net of excise taxes rose modestly to $5.36 billion, slightly ahead of expectations. The company pointed to higher fuel and everyday living costs…
Las Vegas Sands Corp. shares fell in pre-market trading after Argus Research downgraded the stock from Buy to Hold. The downgrade compounds investor caution that has been building since LVS reported weaker-than-expected Q2 2026 results, with management pointing to unusually low hold rates in Macao as the primary driver of the shortfall.
Align Technology stock fell sharply in pre-market trading after the company issued third-quarter 2026 revenue guidance below analyst expectations alongside quarterly results. While quarterly revenue and adjusted earnings per share were broadly in line and clear aligner volume hit a record, weakness in Systems and Services, a £37.5 million (reported…
ImmunityBio (NASDAQ:IBRX) saw its stock climb 7.5% on Thursday after the Emirates Drug Establishment granted marketing authorizations for ANKTIVA across two indications: BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) in combination with BCG, and metastatic non-small cell lung cancer (NSCLC) in combination with immune checkpoint inhibit…
The European Commission has unveiled plans to finance seven AI gigafactories across the European Union with a budget of €10 billion, up from an initial five, and aims to attract at least €20 billion in private investment. The facilities will integrate advanced AI processors, software, cloud infrastructure, high-speed connectivity and data centres, …
